Other languages Tyra Biosciences, Inc.

Equities

TYRA

US90240B1061

Market Closed - Nasdaq Other stock markets 04:30:01 2024-05-03 pm EDT			5-day change	1st Jan Change
17.85 ^USD	-3.67%		+13.91%	+28.88%

Mar. 20	HC Wainwright Adjusts Tyra Biosciences Price Target to $23 From $19, Maintains Buy Rating	MT
Mar. 19	Tyra Biosciences Q4 Net Loss Widens	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Tyra Biosciences Q4 Net Loss Widens	Mar. 19
Tyra Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 19
Tyra Biosciences, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 19
Sector Update: Health Care Stocks Advance Late Afternoon	Feb. 02
Sector Update: Health Care	Feb. 02
Tyra Biosciences Launches $200 Million Private Placement; Shares Rise	Feb. 02
Top Midday Gainers	Feb. 02
Tyra Biosciences Launches $200 Million Private Placement; Shares Rise	Feb. 02
Tyra Biosciences Receives FDA Rare Pediatric Disease Designation for Potential Achondroplasia Treatment	Feb. 02
Tyra Biosciences, Inc. Receives FDA Rare Pediatric Disease Designation for TYRA-300 for the Treatment of Achondroplasia	Feb. 01
Tyra Biosciences, Inc. Doses First Patient with TYRA-200 and Provides Positive Updates on TYRA-300	Dec. 22
Tyra Biosciences Doses 1st Patient in Phase 1 Liver Cancer Treatment Trial	Dec. 22
Tyra Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 07
Tyra Biosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-10
Tyra Biosciences Announces Fda Orphan Drug Designation for Tyra-300 for the Treatment of Achondroplasia	23-08-01
Insider Sell: Tyra Biosciences	23-06-22
Insider Sell: Tyra Biosciences	23-06-16
Insider Sell: Tyra Biosciences	23-06-16
Tyra Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-04
Tyra Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-22

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Tyra Biosciences, Inc.

Equities

TYRA

US90240B1061

Other languages

Filters